Table 2 Acute toxicity evaluation per patient.
| Â | Chemoradiation period (n = 31) | Consolidation chemotherapy period (n = 21) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Acute Toxicity | Grade (No. of patients) | Incidence of ≥ Grade 3 | Grade (No. of patients) | Incidence of ≥ Grade 3 | ||||||
| Â | 1 | 2 | 3 | 4 | (%) | 1 | 2 | 3 | 4 | (%) |
Hematological | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Neutopenia | 2 | 3 | 3 | 0 | 9.7 | 0 | 3 | 2 | 5 | 33.3 |
   Anemia | 5 | 6 | 1 | 0 | 3.2 | 2 | 4 | 0 | 0 | 0 |
   Thrombocytopenia | 0 | 0 | 2 | 0 | 6.5 | 0 | 0 | 0 | 2 | 9.5 |
   Febrile neutropenia | 0 | 0 | 2 | 0 | 6.5 | 0 | 0 | 2 | 0 | 9.5 |
Non-hematological | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Stomatitis | 1 | 4 | 0 | 0 | 0 | 3 | 4 | 0 | 0 | 0 |
   Diarrhea | 3 | 9 | 0 | 0 | 0 | 2 | 4 | 0 | 0 | 0 |
   Constipation | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
   Nausea/vomiting | 3 | 16 | 0 | 0 | 0 | 3 | 7 | 0 | 0 | 0 |
   Asthenia | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 4.8 |
   Abdominal pain | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
   Infection | 0 | 2 | 1 | 0 | 3.2 | 0 | 0 | 0 | 0 | 0 |
   Dermatitis | 3 | 6 | 17 | 0 | 54.8 | 0 | 0 | 0 | 0 | 0 |